RE:$1.60 per share in perceived valueAmigo11 wrote: Strip out cash of $1.80 per share or thereabouts and there is less perceived future value in the stock than the cash component.Without significant indebtedness it is clear that "the market" believes that this is a real long shot.I am willing to pay current pricing for a warrant on the analgesic industry that doesn't expire.I don't know when it turns but .....
At 65M shares, I see the cash at $1.10
Looking at the minimum likely intake with larger geography partnerships and I see an additional $2.98 CAD in 2022. Then remove the cash we spend over 2021-2022 and that's likely around $50M ($0.77 per share).
You quickly see what we likely have in the bank going into 2023. If share only trade at 3x cash (like it's doing now) ... you quickly see where the price could be.
Then in 2022, the NASDAQ will help us value our shares much higher than 3x cash, with everything that's happening ... hard to think the shares will only be at 3x cash. I'm also thinking a partner or partners will be forking the bills for P3 and we'll be creating new entities during that time.
That ... my friend ... is why I started buying again below 40 cents and why I continue to buy today. H2S is highly unknown and people don't really get it yet. That will come quickly ... when it comes.
All in my opinion though.
Happy "whatever" holiday it is today folks !!!!!